Profile: Mirabel Medical Systems Ltd. offers solutions for the non-invasive, cost-effective detection of breast cancer, based on a powerful and patented new technology called electrical impedance scanning (EIS). In addition to breast cancer detection, the new technology can be applied to other clinical applications. The EIS is a pioneering means for breast cancer screening in young women. The EIS, along with clinical breast exam (CBE), can provide an effective tool for detecting carcinoma in women under the recommended age for mammography, before the disease becomes life threatening.

The company has revenues of < USD 1 Million, has ~20 employees and is ISO 9001, CE certified.